Clinical Trial: A Study Comparing Tapinarof Cream 1% and Vtama(R) Cream 1% in the Treatment of Plaque Psoriasis.

U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT07546214) titled 'A Study Comparing Tapinarof Cream 1% and Vtama(R) Cream 1% in the Treatment of Plaque Psoriasis.' on April 15.

Brief Summary: To demonstrate therapeutic equivalence and safety of Tapinarof Cream, 1% (Sun pharma Canada, Inc.) and Vtama(R) (Tapinarof) Cream, 1% in the treatment of plaque psoriasis.

Study Start Date: Oct. 13, 2025

Study Type: INTERVENTIONAL

Condition: Plaque Psoriasis

Intervention: DRUG: Tapinarof Cream, 1%

The investigational product will be self-applied topically to the affected areas of the face once daily in the evening for 84 consecutive days.

DRUG: Vtama(R) (Tapinarof) Cream, 1%

The investigational prod...